Morrow M - Search Results

1

Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.

Gapstur SM, Morrow M, Sellers TA. Gapstur SM, et al. Among authors: morrow m. JAMA. 1999 Jun 9;281(22):2091-7. doi: 10.1001/jama.281.22.2091. JAMA. 1999. PMID: 10367819

2

Pre-cancerous breast lesions: implications for breast cancer prevention trials.

Morrow M. Morrow M. Int J Radiat Oncol Biol Phys. 1992;23(5):1071-8. doi: 10.1016/0360-3016(92)90915-5. Int J Radiat Oncol Biol Phys. 1992. PMID: 1322385 Review.

3

Patient selection for breast conservation therapy with magnification mammography.

Morrow M, Schmidt R, Hassett C. Morrow M, et al. Surgery. 1995 Oct;118(4):621-6. doi: 10.1016/s0039-6060(05)80027-3. Surgery. 1995. PMID: 7570314

4

The woman at increased risk for breast cancer: evaluation and management strategies.

Bilimoria MM, Morrow M. Bilimoria MM, et al. Among authors: morrow m. CA Cancer J Clin. 1995 Sep-Oct;45(5):263-78. doi: 10.3322/canjclin.45.5.263. CA Cancer J Clin. 1995. PMID: 7656130 Free article. Review.

5

Identification and management of the woman at increased risk for breast cancer development.

Morrow M. Morrow M. Breast Cancer Res Treat. 1994;31(1):53-60. doi: 10.1007/BF00689676. Breast Cancer Res Treat. 1994. PMID: 7981457 Review.

6

Breast cancer in young women: issues in local therapy.

Morrow M, Hassett C. Morrow M, et al. J Natl Cancer Inst Monogr. 1994;(16):79-84. J Natl Cancer Inst Monogr. 1994. PMID: 7999474 Review.

7

A 47-year-old woman with ductal carcinoma in situ.

Morrow M. Morrow M. JAMA. 1996 Jan 3;275(1):61-6. JAMA. 1996. PMID: 8531289 No abstract available.

8

Medical contraindications are not a major factor in the underutilization of breast conserving therapy.

Morrow M, Bucci C, Rademaker A. Morrow M, et al. J Am Coll Surg. 1998 Mar;186(3):269-74. doi: 10.1016/s1072-7515(97)00153-1. J Am Coll Surg. 1998. PMID: 9510257

9

Identification of the woman at risk for breast cancer: problem solved?

Morrow M. Morrow M. Recent Results Cancer Res. 1999;151:85-95. doi: 10.1007/978-3-642-59945-3_6. Recent Results Cancer Res. 1999. PMID: 10337720 Review.

10

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. Cummings SR, et al. Among authors: morrow m. JAMA. 1999 Jun 16;281(23):2189-97. doi: 10.1001/jama.281.23.2189. JAMA. 1999. PMID: 10376571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,263 results

Search Page

Filters